Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gland Pharma and KKR & Co LP enter into agreement


Wednesday, 27 Nov 2013 11:00pm EST 

Gland Pharma Limited:Enters an agreement under which KKR will acquire a minority stake in the Gland Pharma Ltd for approximately $200 million, including KKR`s acquisition of the entire stake held by Evolvence India Life Sciences Fund (EILSF), an existing private equity investor in Gland Pharma. 

Company Quote

22.82
0.05 +0.22%
4:02pm EDT